I was asked by senior reporter for The Defender, Michael Nevradakis, Ph.D., to comment on Pfizer’s delay of their myocarditis study in kids and young adults to 2030.
My published comments can be read …
Keep reading with a 7-day free trial
Subscribe to Sonia Elijah investigates to keep reading this post and get 7 days of free access to the full post archives.